首发丨春雨医生完成E轮战略融资,重启五芒星创新探索

2020-09-10 佚名 漆叶青

今日,春雨医生宣布完成E轮战略融资,本轮融资由搜狗科技领投,华新、华锦基金跟投。

今日,春雨医生宣布完成E轮战略融资,本轮融资由搜狗科技领投,华新、华锦基金跟投。

诞生于2011年7月的春雨医生,迄今已经在移动医疗领域深耕了九年多的时间,先后推出了在线问诊、空中诊所、家庭医生、开放平台、健康小站和互联网医院等创新医疗服务模式。

其中,围绕在线问诊,春雨医生经过多年积累,搭建了“速度、专业度、服务态度”三位一体的在线问诊服务质量控制体系。并在此基础上,将“在线问诊开放平台”接入百度、华为、泰康、阳光保险、中意保险、中英保险等700余家合作方,同时坚持在线问诊AI化的探索实践,大大提升了医患匹配的效率和准确度。

根据春雨医生公布的数据,截至2020年8月,春雨医生共聚集中国真实在院执业医生超过63万,覆盖全科;累计注册用户逾1.3亿;日咨询量峰值超过30万次。

今年上半年,新冠肺炎疫情爆发后,春雨医生也迅速行动,全面放开呼吸科、感染科、心理科等急需科室进行线上义诊,累计服务超过153万患者,为阻断疫情传播、保障人民群众基础医疗健康做出了贡献。

本轮融资后,春雨医生表示,将重启对五芒星模型的创新实践,继续夯实互联网问诊核心业务,提升问诊AI和医疗大数据应用,探索由问诊到医院、医药、慢病管理和新型健康险为一体的医疗健康全服务体系创新。

五芒星模型

五芒星模型由春雨医生创始人张锐在2015年提出,在他看来,五芒星模型有5个端点:医生、患者、医院、医药/器械、保险。按照其规划,春雨医生要在五芒星模型里一步步探索两方之间甚至多方之间的连接,让春雨逐渐从一个医患连接的平台,逐渐进化为一个医疗服务生态(医、药、险等)的连接平台。

从行业整体来看,疫情成为了互联网医疗机构提升用户规模和渗透率的意外之机,同时也再度催发了资本对互联网医疗投资的热情——已经上市的平安好医生、1药网、阿里健康上半年因疫情股价、市值接连攀升,而微医、京东健康也接连公布了上市规划。

至于春雨医生,在此轮融资前,春雨医生先后完成了六轮融资,其中,值得注意的是,今年3月初,春雨医生新增企业股东——北京搜狗信息服务有限公司。工商变更完成后,搜狗位列春雨医生第七大股东,持股比例6.39%。同时,搜狗CEO王小川出任春雨医生董事一职。

春雨医生此前历轮融资情况

针对二者的联手,根据媒体报道,王小川3月时曾对此表示,搜狗本身的搜索就承接了大量用户对于医疗相关的查询,接近10%的搜索请求都与医疗相关。后续会加强医疗相关的AI信息服务能力,迎接更多的搜索需求,最后发展长久独立的业务,打造互联网数字家庭医生。从今年的布局中,医疗能够从搜索获得帮助并获得独立的用户资源,这也是投资春雨医生的原因。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1668719, encodeId=9b8d1668e198c, content=<a href='/topic/show?id=0e3859e06ee' target=_blank style='color:#2F92EE;'>#春雨医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59706, encryptionId=0e3859e06ee, topicName=春雨医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0f26388099, createdName=xjy11, createdTime=Sun Nov 29 01:39:23 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888457, encodeId=a4d988845e34, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=23017AF9A43E478B081BD06235BF844F, createdBy=e98c5416040, createdName=ms3000001121456932, createdTime=Sat Sep 26 07:21:50 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285910, encodeId=0c98128591098, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459110, encodeId=d0e314591103c, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884505, encodeId=bc5388450551, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>好, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c495209553, createdName=1475877fm90暂无昵称, createdTime=Fri Sep 11 10:47:41 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048152, encodeId=a37b1048152bf, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 11 02:39:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884378, encodeId=3a0b8843e8dc, content=祝福, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200729/2ee0ca079ce64987b1195eb6aa20a1f4/ae923a98c9704879bacdc81d9fa7479a.jpg, createdBy=a3ab5398909, createdName=ms6000001113694287, createdTime=Thu Sep 10 23:41:48 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1668719, encodeId=9b8d1668e198c, content=<a href='/topic/show?id=0e3859e06ee' target=_blank style='color:#2F92EE;'>#春雨医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59706, encryptionId=0e3859e06ee, topicName=春雨医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0f26388099, createdName=xjy11, createdTime=Sun Nov 29 01:39:23 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888457, encodeId=a4d988845e34, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=23017AF9A43E478B081BD06235BF844F, createdBy=e98c5416040, createdName=ms3000001121456932, createdTime=Sat Sep 26 07:21:50 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285910, encodeId=0c98128591098, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459110, encodeId=d0e314591103c, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884505, encodeId=bc5388450551, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>好, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c495209553, createdName=1475877fm90暂无昵称, createdTime=Fri Sep 11 10:47:41 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048152, encodeId=a37b1048152bf, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 11 02:39:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884378, encodeId=3a0b8843e8dc, content=祝福, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200729/2ee0ca079ce64987b1195eb6aa20a1f4/ae923a98c9704879bacdc81d9fa7479a.jpg, createdBy=a3ab5398909, createdName=ms6000001113694287, createdTime=Thu Sep 10 23:41:48 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-26 ms3000001121456932

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1668719, encodeId=9b8d1668e198c, content=<a href='/topic/show?id=0e3859e06ee' target=_blank style='color:#2F92EE;'>#春雨医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59706, encryptionId=0e3859e06ee, topicName=春雨医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0f26388099, createdName=xjy11, createdTime=Sun Nov 29 01:39:23 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888457, encodeId=a4d988845e34, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=23017AF9A43E478B081BD06235BF844F, createdBy=e98c5416040, createdName=ms3000001121456932, createdTime=Sat Sep 26 07:21:50 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285910, encodeId=0c98128591098, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459110, encodeId=d0e314591103c, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884505, encodeId=bc5388450551, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>好, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c495209553, createdName=1475877fm90暂无昵称, createdTime=Fri Sep 11 10:47:41 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048152, encodeId=a37b1048152bf, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 11 02:39:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884378, encodeId=3a0b8843e8dc, content=祝福, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200729/2ee0ca079ce64987b1195eb6aa20a1f4/ae923a98c9704879bacdc81d9fa7479a.jpg, createdBy=a3ab5398909, createdName=ms6000001113694287, createdTime=Thu Sep 10 23:41:48 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1668719, encodeId=9b8d1668e198c, content=<a href='/topic/show?id=0e3859e06ee' target=_blank style='color:#2F92EE;'>#春雨医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59706, encryptionId=0e3859e06ee, topicName=春雨医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0f26388099, createdName=xjy11, createdTime=Sun Nov 29 01:39:23 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888457, encodeId=a4d988845e34, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=23017AF9A43E478B081BD06235BF844F, createdBy=e98c5416040, createdName=ms3000001121456932, createdTime=Sat Sep 26 07:21:50 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285910, encodeId=0c98128591098, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459110, encodeId=d0e314591103c, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884505, encodeId=bc5388450551, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>好, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c495209553, createdName=1475877fm90暂无昵称, createdTime=Fri Sep 11 10:47:41 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048152, encodeId=a37b1048152bf, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 11 02:39:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884378, encodeId=3a0b8843e8dc, content=祝福, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200729/2ee0ca079ce64987b1195eb6aa20a1f4/ae923a98c9704879bacdc81d9fa7479a.jpg, createdBy=a3ab5398909, createdName=ms6000001113694287, createdTime=Thu Sep 10 23:41:48 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-12 zhao4618
  5. [GetPortalCommentsPageByObjectIdResponse(id=1668719, encodeId=9b8d1668e198c, content=<a href='/topic/show?id=0e3859e06ee' target=_blank style='color:#2F92EE;'>#春雨医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59706, encryptionId=0e3859e06ee, topicName=春雨医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0f26388099, createdName=xjy11, createdTime=Sun Nov 29 01:39:23 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888457, encodeId=a4d988845e34, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=23017AF9A43E478B081BD06235BF844F, createdBy=e98c5416040, createdName=ms3000001121456932, createdTime=Sat Sep 26 07:21:50 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285910, encodeId=0c98128591098, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459110, encodeId=d0e314591103c, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884505, encodeId=bc5388450551, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>好, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c495209553, createdName=1475877fm90暂无昵称, createdTime=Fri Sep 11 10:47:41 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048152, encodeId=a37b1048152bf, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 11 02:39:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884378, encodeId=3a0b8843e8dc, content=祝福, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200729/2ee0ca079ce64987b1195eb6aa20a1f4/ae923a98c9704879bacdc81d9fa7479a.jpg, createdBy=a3ab5398909, createdName=ms6000001113694287, createdTime=Thu Sep 10 23:41:48 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1668719, encodeId=9b8d1668e198c, content=<a href='/topic/show?id=0e3859e06ee' target=_blank style='color:#2F92EE;'>#春雨医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59706, encryptionId=0e3859e06ee, topicName=春雨医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0f26388099, createdName=xjy11, createdTime=Sun Nov 29 01:39:23 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888457, encodeId=a4d988845e34, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=23017AF9A43E478B081BD06235BF844F, createdBy=e98c5416040, createdName=ms3000001121456932, createdTime=Sat Sep 26 07:21:50 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285910, encodeId=0c98128591098, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459110, encodeId=d0e314591103c, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884505, encodeId=bc5388450551, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>好, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c495209553, createdName=1475877fm90暂无昵称, createdTime=Fri Sep 11 10:47:41 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048152, encodeId=a37b1048152bf, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 11 02:39:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884378, encodeId=3a0b8843e8dc, content=祝福, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200729/2ee0ca079ce64987b1195eb6aa20a1f4/ae923a98c9704879bacdc81d9fa7479a.jpg, createdBy=a3ab5398909, createdName=ms6000001113694287, createdTime=Thu Sep 10 23:41:48 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-11 CHANGE

    又是钱!医学需要投资呀,赞!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1668719, encodeId=9b8d1668e198c, content=<a href='/topic/show?id=0e3859e06ee' target=_blank style='color:#2F92EE;'>#春雨医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59706, encryptionId=0e3859e06ee, topicName=春雨医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c0f26388099, createdName=xjy11, createdTime=Sun Nov 29 01:39:23 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888457, encodeId=a4d988845e34, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png;jsessionid=23017AF9A43E478B081BD06235BF844F, createdBy=e98c5416040, createdName=ms3000001121456932, createdTime=Sat Sep 26 07:21:50 CST 2020, time=2020-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285910, encodeId=0c98128591098, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459110, encodeId=d0e314591103c, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Sat Sep 12 14:39:23 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884505, encodeId=bc5388450551, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>好, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c495209553, createdName=1475877fm90暂无昵称, createdTime=Fri Sep 11 10:47:41 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048152, encodeId=a37b1048152bf, content=又是钱!医学需要投资呀,赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Fri Sep 11 02:39:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884378, encodeId=3a0b8843e8dc, content=祝福, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200729/2ee0ca079ce64987b1195eb6aa20a1f4/ae923a98c9704879bacdc81d9fa7479a.jpg, createdBy=a3ab5398909, createdName=ms6000001113694287, createdTime=Thu Sep 10 23:41:48 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-10 ms6000001113694287

    祝福

    0

相关资讯

BioNTech为其mRNA癌症个性化疫苗平台融资2.9亿欧元

德国BioNTech在第二轮融资中筹集了高达2.9亿欧元(3.25亿美元)的资金,这是欧洲生物技术公司有史以来最大的融资之一。

Finch Therapeutics融资5300万美元,推进其微生物疗法预防艰难梭菌感染

Finch Therapeutics已经完成了C轮融资,筹集了5300万美元用于推进其微生物疗法管线,利用细菌培养物来恢复我们体内细菌菌落的自然平衡。

Citryll融资1500万欧元开发中和中性粒细胞外陷阱(NETs)的抗体,治疗自身免疫性疾病

荷兰生物技术公司Citryll筹集了1500万欧元(合1700万美元)的第一轮融资,以推进其针对自身免疫性疾病的新治疗方法。该公司正在开发一种基于抗体的平台,研发可用于阻止中性粒细胞胞外陷阱(NETs)形成的抗体。

南京维立志博生物完成新一轮近亿元融资

据南京维立志博生物科技有限公司(维立志博)官方微信消息,其于近期顺利完成新一轮融资近亿元人民币。本轮融资由上海建信资本、恩然创投、重山资本等原有投资人以及华方资本、怀格资本等新投资人共同出资完成。本轮融资款将用于把现有抗体新药产品快速推进至临床研究阶段,同时推进其他在研项目的临床前研究,拓展新的研发管线项目。

克睿基因获1700万美元A轮融资,启明创投领投

苏州克睿基因生物科技有限公司(简称“克睿基因”)今日宣布已完成1700万美元A轮融资。本轮融资由启明创投领投,清松资本、盛鼎投资共同投资。

泰莱生物获千万Pre-A轮融资,加速癌症多组学液体活检开发

近日,生物科技公司泰莱生物已完成数千万元Pre-A轮融资,由瑞伏医疗健康基金、康圣环球和鲲鹏医疗天使基金等共同投资。